Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controlsXiaoyu Zhao, Juncheng Dai, Yifan Wang et al.|Cancer|2023Cited by 8
A phase-1 dose escalation and expansion study of EP0031, a next-generation selective RET inhibitor (SRI), in patients with SRI-naïve or pretreated advanced RET-altered NSCLC and other tumors.Elena Garralda, Pilar Garrido, Judy S. Wang et al.|Journal of Clinical Oncology|2024Cited by 2